BIRMINGHAM CENTRE FOR CANCER AND GENOMIC MEDICINE LLPActive
Key figures
Ratios
2023/24Balance sheet structure
Filed accounts2022/23–2023/24
| 2022/23 | 2023/24 | |
|---|---|---|
| Turnover | 0 | 7,850 |
| Profit for the year | 0 | 0 |
| Cash at bank and in hand | 3 | 600 |
| Total assets | — | 5,650 |
| Total liabilities | — | — |
| Net assets / total equity | — | — |
| Average number of employees | 0 | 0 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Summary: BIRMINGHAM CENTRE FOR CANCER AND GENOMIC MEDICINE LLP
Company
BIRMINGHAM CENTRE FOR CANCER AND GENOMIC MEDICINE LLP is a limited liability partnership registered with Companies House under company number OC444594. It was incorporated on 9 Nov 2022. Its status is active. The registered office is in Birmingham (B68).
Accounts
The latest accounts in the database are for 2023/24 (period ending 31 Mar 2024); the company files abridged accounts (unaudited). Turnover was £7,850. Profit for the year was £0. Cash at bank and in hand was £600. The company had an average of 0 employees. Figures are available for 2 financial years (2022/23–2023/24).
Control and charges
2 persons with significant control are registered.
Filing deadlines
The next accounts are due by 31 Dec 2026. The next confirmation statement is due by 22 Nov 2026.